相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast cancer: are long-term and intermittent endocrine therapies equally effective?
Jutta Engel et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
Zuzana Kos et al.
NPJ BREAST CANCER (2020)
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nora Pashayan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
An immune-related prognostic signature for predicting breast cancer recurrence
Zelin Tian et al.
CANCER MEDICINE (2020)
Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway
Mette H. Moller et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The role of Survivin as a biomarker and potential prognostic factor for breast cancer
Glaucia Luciano da Veiga et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2019)
Polymorphisms in Survivin (BIRC5 Gene) Are Associated with Age of Onset in Breast Cancer Patients
Ilona Susac et al.
JOURNAL OF ONCOLOGY (2019)
Systemic treatment of patients with early breast cancer: recent updates and state of the art
Rafael Caparica et al.
BREAST (2019)
Expression of survivin does not appear to influence breast cancer recurrence risk
Lindsay J. Collin et al.
ACTA ONCOLOGICA (2019)
Breast cancer survival trends in different stages and age groups - a population-based study 1989-2013
Anna E. Nordenskjold et al.
ACTA ONCOLOGICA (2019)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (vol 28, pg 1700, 2017)
G. Curigliano et al.
ANNALS OF ONCOLOGY (2019)
Immune gene expression profiling reveals heterogeneity in luminal breast tumors
Bin Zhu et al.
BREAST CANCER RESEARCH (2019)
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses
Pawan Poudel et al.
NPJ BREAST CANCER (2019)
Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer
Miriam Nuncia-Cantarero et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Molecular Subtypes and Local-Regional Control of Breast Cancer
Simona Maria Fragomeni et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients
Washaakh Ahmed et al.
MOLECULAR BIOLOGY REPORTS (2018)
Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ
Milca Cezar Chade et al.
EINSTEIN-SAO PAULO (2018)
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers
Takayuki Iwamoto et al.
ONCOTARGET (2017)
Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
Sha Li et al.
ONCOTARGET (2017)
A review of the importance of immune responses in luminal B breast cancer
Delia J. Nelson et al.
ONCOIMMUNOLOGY (2017)
Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
Wanlu Li et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
A. S. Hamy et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Survivin: a unique target for tumor therapy
Himani Garg et al.
CANCER CELL INTERNATIONAL (2016)
Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis
Ke-yan Cheng et al.
PLOS ONE (2016)
Clinical significance of survivin and vascular endothelial growth factor mRNA detection in the peripheral whole blood of breast cancer patients
S. Wang et al.
NEOPLASMA (2016)
No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study
A. E. Nordenskjold et al.
ANNALS OF ONCOLOGY (2015)
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
Lao H. Saal et al.
GENOME MEDICINE (2015)
Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression
Jenny G. Parvani et al.
NEOPLASIA (2015)
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
Michael R. Clemens et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Early diagnostic value of survivin and its alternative splice variants in breast cancer
Salma Khan et al.
BMC CANCER (2014)
Prognostic Significance of Survivin in Breast Cancer: Meta-analysis
Yanyan Li et al.
BREAST JOURNAL (2014)
Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
Ying-Chun Zhao et al.
MOLECULAR MEDICINE REPORTS (2014)
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors
Alice Faversani et al.
BREAST CANCER RESEARCH (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Survivin promotion of melanoma metastasis requires upregulation of α5 integrin
Jodi A. McKenzie et al.
CARCINOGENESIS (2013)
Prognostic value of proliferation markers expression in breast cancer
Natalija Dedic Plavetic et al.
MEDICAL ONCOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Prognostic value of survivin expression in breast cancer patients: a meta-analysis
Jian Song et al.
TUMOR BIOLOGY (2013)
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
Pascal Jezequel et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2013)
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
Pascal Jezequel et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
Juergen C. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes
Benjamin Haibe-Kains et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Survivin expression and targeting in breast cancer
Kumkum Jha et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Survivin As a Predictive Biomarker of Complete Pathologic Response to Neoadjuvant Chemotherapy in Patients With Stage II and Stage III Breast Cancer
Cristiane Rios Petrarca et al.
CLINICAL BREAST CANCER (2011)
YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer
Kentaro Yamanaka et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
Elton Rexhepaj et al.
BMC CANCER (2010)
Antitumor cytotoxic T-cell response induced by a survivin peptide mimic
Michael J. Ciesielski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Molecular dependence of estrogen receptor-negative breast cancer on a Notch-survivin signaling axis
Connie W. Lee et al.
CANCER RESEARCH (2008)
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
Donal J. Brennan et al.
CLINICAL CANCER RESEARCH (2008)
A functional Notch-survivin gene signature in basal breast cancer
Connie W. Lee et al.
BREAST CANCER RESEARCH (2008)
Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
A. R. Hinnis et al.
BRITISH JOURNAL OF CANCER (2007)
Molecular classification of breast cancer: Limitations and potential
Lajos Pusztai et al.
ONCOLOGIST (2006)
Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis
M Bokarewa et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prognostic importance of survivin in breast cancer
SM Kennedy et al.
BRITISH JOURNAL OF CANCER (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
